Earnings Release • Oct 26, 2016
Earnings Release
Open in ViewerOpens in native device viewer
Ieper, Belgium – October 26th, 2016, 07.00 hrs CET
Sales for the third quarter of 2016 were 114.5 million EUR, an increase of 13% compared to the same quarter of the previous year and an increase of 2% compared to the previous quarter.
The EUR/USD exchange rate evolution had no impact, both compared to the same quarter of last year and the previous quarter.
Gross margin was 53.2 million EUR, an increase of 11% compared to the same quarter of last year and an increase of 4% compared to the previous quarter.
R&D expenses were 13.9% of sales, G&A was at 4.5% of sales and Selling was at 2.0% of sales. The operating result was 29.7 million EUR, an increase of 9% compared to the same quarter of last year and an increase of 7% compared to the previous quarter.
Net income was 25.2 million EUR or 0.62 EUR per share, an increase of 1% compared to 25.0 million EUR or 0.62 EUR per share in the third quarter of 2015 and an increase of 9% compared to 23.1 million EUR or 0.57 EUR per share in the previous quarter.
Melexis expects a full year sales growth around the level of 13-14%, a gross profit margin around 45% and an operating margin around 25%, all taking into account a EUR/USD exchange rate of 1.10.
"In the third quarter of 2016, Melexis continued its growth path with a year over year double-digit sales increase, outperforming market growth. We are happy to see continued growth in a number of Melexis core ASSP product lines such as position sensors, fan drivers and LIN (local interconnect networking). Geographically, EMEA was the main growth driver compared to the previous quarter. Based on the current order book, Melexis confirms its full year outlook.
In the third quarter, sales to automotive customers represented 89% of total sales. The portion of standard product (ASSPs) sales represented 62% of total sales."
The company's results will be discussed in a conference call on Wednesday, October 26th, 2016 at 17 hrs CET. The conference call will be in English. You have to register for this conference call in advance. You can register by clicking on the following link and filling out the requested information: https://eventreg2.conferencing.com/webportal3/reg.html?Acc=179908&Conf=222635 Conference ID: 960308.
After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes all participants must register individually if they wish to join the call.
A replay number for this call is available for 7 days after the end of the conference call. The replay number for this call is +32 2 290 17 05, access code: 960308.
For further information: Investor Relations Phone: +32 13 67 07 79 Fax: +32 13 67 21 34 Email: [email protected]
Combining a passion for technology with truly inspired engineering, Melexis designs, develops and delivers innovative micro-electronic solutions that enable designers to turn ideas into applications that support the best imaginable future. The company's advanced mixed-signal semiconductor sensor and actuator components address the challenges of integrating sensing, driving and communication into next-generation products and systems that improve safety, raise efficiency, support sustainability and enhance comfort. Melexis is headquartered in Belgium and employs over 1,100 people in 19 locations worldwide. The company is publicly traded on Euronext Brussels (MELE). For more information, visit www.melexis.com
Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward-looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.
| CONFORM IFRS | Quarter ended 30/09/2016 |
30/09/2015 | Quarter ended Nine months ended 30/09/2016 |
Nine months 30/09/2015 |
Year ended 31/12/2015 |
|---|---|---|---|---|---|
| in k EUR | audited | ||||
| Sales | 114,518 | 101,563 | 336,264 | 297,740 | 400,136 |
| Cost of sales | -61,367 | -53,745 | -182,918 | -153,111 | -208,015 |
| Gross Margin | 53,151 | 47,818 | 153,346 | 144,629 | 192,121 |
| R&D | -15,949 | -13,790 | -46,912 | -40,601 | -56,737 |
| G&A | -5,186 | -4,690 | -15,063 | -13,853 | -19,090 |
| Selling | -2,276 | -2,112 | -6,708 | -6,474 | -8,690 |
| Other operating result | 0 | 0 | 311 | 0 | 0 |
| Operating result | 29,739 | 27,227 | 84,973 | 83,700 | 107,604 |
| Financial result | -683 | -315 | -1,815 | 1,620 | 1,869 |
| Income before taxes | 29,056 | 26,912 | 83,158 | 85,319 | 109,473 |
| Income taxes | -3,864 | -1,885 | -11,994 | -8,264 | -10,402 |
| Net income | 25,193 | 25,026 | 71,164 | 77,055 | 99,071 |
| Net income per share in EUR | 0.62 | 0.62 | 1.76 | 1.91 | 2.45 |
| CONFORM IFRS | Nine months ended 30/09/2016 |
Nine months ended 30/09/2015 |
Year ended 31/12/2015 |
|---|---|---|---|
| in k EUR | audited | ||
| Current Assets : | |||
| Cash and cash equivalents | 109,201 | 109,821 | 73,838 |
| Current investments | 137 | 111 | 49 |
| A/R Trade | 58,000 | 50,077 | 51,243 |
| A/R from related parties | 3,748 | 3,864 | 1,999 |
| Advance related parties | |||
| Assets for current tax | 799 | 995 | 1,384 |
| Assets held for sale | 289 | 289 | |
| Other current assets | 8,493 | 8,335 | 5,237 |
| Inventories | 73,046 | 64,326 | 64,099 |
| Total current assets | 253,424 | 237,819 | 198,140 |
| Non-current assets : | |||
| Costs of incorporation | |||
| Property, plant and equipment | 95,209 | 83,033 | 90,300 |
| Financial assets | 6 | 6 | 6 |
| Intangible fixed assets | 6,806 | 6,646 | 7,440 |
| A/R directors | |||
| Other non-current assets | 7 | 959 | 8 |
| Deferred tax assets | 7,295 | 11,609 | 10,877 |
| Total non current assets | 109,323 | 102,253 | 108,630 |
| Total assets | 362,748 | 340,072 | 306,770 |
| CONFORM IFRS | Nine months ended | Nine months ended | Year ended | |
|---|---|---|---|---|
| 30/09/2016 | 30/09/2015 | 31/12/2015 | ||
| in k EUR | audited | |||
| Liabilities and shareholders Equity | ||||
| Current liabilities : | ||||
| Bank loans and overdrafts | ||||
| Derivative financial instruments | 976 | 1,531 | 1,627 | |
| Current portion of LT debt | 4,046 | 5,046 | 7,046 | |
| A/P trade | 16,088 | 14,359 | 15,247 | |
| Affiliated companies | 16,374 | 10,236 | 10,791 | |
| Accrued taxes | 9,984 | 6,244 | 6,543 | |
| Accrued expenses and payroll | 8,277 | 8,225 | 7,135 | |
| Other current liabilities | 2,498 | 1,615 | 3,258 | |
| Deferred income | 1,308 | 1,790 | 2,358 | |
| Total current liabilities | 59,551 | 49,045 | 54,005 | |
| Non current liabilities : | ||||
| LT debt less current portion | 11,092 | 16,137 | 8,138 | |
| Deferred tax liabilities | ||||
| Other non-current liabilities | 2,228 | 1,967 | 2,116 | |
| Total non current liabilities | 13,320 | 18,104 | 10,254 | |
| Shareholders' equity : | ||||
| Shareholders' capital | 565 | 565 | 565 | |
| Share premium | ||||
| Treasury shares | -3,818 | -3,818 | -3,818 | |
| Revaluation reserve Hedge | -277 | -383 | -372 | |
| Revaluation reserve Fair value | ||||
| Legal reserve | 57 | 57 | 57 | |
| Retained earnings | 228,342 | 205,378 | 153,308 | |
| Current period's profit | 71,164 | 77,055 | 99,071 | |
| Cumulative translation adjustment | -6,167 | -5,942 | -6,311 | |
| Equity attributable to company owners | 289,866 | 272,912 | 242,500 | |
| Non controlling interests | 10 | 10 | 10 | |
| Total shareholders equity | 289,876 | 272,922 | 242,511 | |
| Total liabilities, shareholders' equity | 362,748 | 340,072 | 306,770 | |
| and minority interests |
| CONFORM IFRS | Quarter ended | Quarter ended | Nine months ended | |
|---|---|---|---|---|
| 30/09/2016 | 30/09/2015 | 30/09/2016 | ||
| (in k EUR) | ||||
| Cash flow from operating activities | ||||
| Net income | 25,193 | 25,026 | 71,164 | |
| Adjustments for : | ||||
| Operating activities | 8,093 | 7,375 | 22,422 | |
| Deferred taxes | 1,189 | 3 | 3,582 | |
| Capital grants | 138 | 349 | 428 | |
| Depreciation and amortisation | 6,847 | 6,614 | 18,613 | |
| Unrealized exchange results | -387 | 111 | 61 | |
| Financial result | 306 | 298 | -262 | |
| Operating profit before working capital changes | 33,286 | 32,401 | 93,586 | |
| A/R, Trade | -3,831 | 504 | -6,713 | |
| A/R, affiliates | 3,363 | 3,251 | -1,749 | |
| Other current assets | -224 | -1,086 | -3,010 | |
| Other non current assets | 0 | 0 | 1 | |
| Inventories | -8,121 | -3,097 | -10,651 | |
| A/P | -5,597 | -1,095 | 860 | |
| A/P affiliates | -4,023 | 1,366 | 5,583 | |
| Accrued expenses | -2,886 | 4,027 | 1,024 | |
| Other current liabilities Other non current liabilities |
661 -198 |
-369 1,460 |
-744 -1,588 |
|
| Interest paid | -63 | -107 | -191 | |
| Income tax | 6,127 | -1,128 | 3,559 | |
| Cash flow from operating activities | 18,494 | 36,126 | 79,967 | |
| Cash flow from investing activities | ||||
| Acquisition of subsidiary, net of cash acquired | ||||
| Financial fixed assets | ||||
| Purchase of PPE and intangible assets (netted) | -4,593 | -8,836 | -20,939 | |
| Interest received | 6 | 36 | 77 | |
| Investments/proceeds/ from current investments | -137 | 240 | -88 | |
| (incl. financial instruments) | ||||
| Cash provided from investing activities | -4,724 | -8,559 | -20,950 | |
| Cash flows from financing activities Payment to acquire own shares |
||||
| Proceeds/Repayment of long-and short-term debt | -1 | -1,922 | -47 | |
| Proceeds/Repayment of bank loans and overdrafts | ||||
| Proceeds from (repayment of) related party financing | ||||
| Impact of exchange results on financing items | 119 | 3,245 | 452 | |
| Dividend payment | 0 | -24,038 | ||
| Capital Decrease | ||||
| Non controlling interests | ||||
| Cash provided from financing activities | 117 | 1,323 | -23,633 | |
| CTA | -7 | -1 | -21 | |
| Increase/decrease in cash and cash equivalents | 13,880 | 28,889 | 35,363 | |
| Cash at beginning of the period | 95,321 | 80,931 | 73,838 | |
| Cash at the end of the period | 109,201 | 109,821 | 109,201 |
| Q3/16 | Q3/15 | Q2/16 | 9M 2016 | 9M 2015 | |
|---|---|---|---|---|---|
| APAC Asia Pacific |
46% | 45% | 47% | 45% | 46% |
| EMEA Europe - Middle-East - Africa |
40% | 41% | 39% | 41% | 40% |
| NALA North America - Latin America |
14% | 14% | 14% | 14% | 14% |
| TOTAL | 100% | 100% | 100% | 100% | 100% |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.